Literature DB >> 7835843

Lymphocytic infiltration and destruction of parathyroid adenomas: a possible tumour-specific autoimmune reaction in two cases of primary hyperparathyroidism.

B Veress1, J Nordenström.   

Abstract

Two cases of primary hyperparathyroidism with underlying parathyroid adenomas were found to be associated with lymphocytic infiltration and destruction of the neoplastic tissue. There was no inflammatory infiltrate in the adjacent rim of the remnant of parathyroid gland or in the other tumour-free glands. The lymphoid cell population within the tumours was composed of both infiltrating T-cells and compact nodule-forming B-cells. In one of the tumours there was considerable fibrosis and atrophy of the adenomatous tissue. The histological picture was consistent with an autoimmune process directed against the adenomas, indicating that this reaction had, in part, been successful in reducing the abnormal cell population.

Entities:  

Mesh:

Year:  1994        PMID: 7835843     DOI: 10.1111/j.1365-2559.1994.tb01356.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

Review 1.  [Inflammation of the parathyroid glands].

Authors:  S Ting; S Synoracki; S-Y Sheu; K W Schmid
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

2.  Parathyroid chief cell adenoma associated with massive chronic parathyroiditis in a woman with hyperparathyroidism.

Authors:  Kalman Kovacs; Cecil David Bell; Jonathan Juco; Fabio Rotondo; Jennifer Anderson
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

3.  Parathyroid adenomas with pronounced lymphocytic infiltration: no evidence of autoimmune pathogenesis.

Authors:  K Y Lam; A C Chan; C Y Lo
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

4.  Parathyroid adenoma with prominent lymphocytic infiltrate.

Authors:  Alexandros Iliadis; Triantafyllia Koletsa; Ioannis Kostopoulos; Georgia Karayannopoulou
Journal:  Case Rep Pathol       Date:  2015-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.